Widespread conflicts of interest among patient-advocacy organizations uncovered

Over the past few decades, hundreds of patient-advocacy organizations have emerged in the United States, promoting disease research and influencing FDA and health insurer policies. Now, a new study reveals a large proportion of these organizations have funding or other connections with drug or medical device makers, yet do not adequately disclose the details of these connections or have publicly accessible policies in place describing how they manage them.
Source: Feed4

Leave a Reply

Your email address will not be published. Required fields are marked *